Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 21, 2017
Omadacycline Receives Qualified Infectious Disease Product Designation from FDA for an Additional Indication in Uncomplicated Urinary Tract Infections
BOSTON, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
September 21, 2017
Lipocine Announces Motions Decision by USPTO in Interference Against Clarus
SALT LAKE CITY , Sept. 21, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced that the Patent Trial and Appeal ...
September 21, 2017
Krystal Biotech Announces Presentation of KB103 Data at EB2017 - The 5th World Conference of EB Research
PITTSBURGH, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (“Krystal”)(KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering ...
September 21, 2017
Rexahn Pharmaceuticals to Present at the 2017 Disruptive Growth Company Showcase NYC
ROCKVILLE, Md., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE AMERICAN:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment ...
September 21, 2017
Advaxis to Webcast Company Overview at the Cantor Fitzgerald Global Healthcare Conference
PRINCETON, N.J.-- (BUSINESS WIRE) -- Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced its company ...
September 20, 2017
DelMar Pharmaceuticals Announces $10 Million Registered Direct Offering Priced At-The-Market
VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 20, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the ...
September 20, 2017
Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2017 Results; Teleconference and Webcast to be held on September 25, 2017
CRANBURY, N.J., Sept. 20, 2017 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter and fiscal year end 2017 operating results ...
September 20, 2017
Kiadis Pharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ATIR101™
Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative products to make bone marrow ...
September 20, 2017
DelMar Pharmaceuticals Announces Issuance of New Patent on First-in-Class DNA-targeting Agent, VAL-083
VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 20, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the ...
September 20, 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
CUPERTINO, Calif., Sept. 20, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) announced today that Dr. Myriam Theeuwes has joined DURECT as Senior Vice President, Clinical Development. ...
September 20, 2017
HTG Announces Issuance of Two Method Patents Related to its Technology
TUCSON, Ariz., Sept. 20, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today ...
September 20, 2017
Lipocine Announces FDA Advisory Committee Meeting for TLANDO™
SALT LAKE CITY, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced that the Bone, Reproductive and Urologic Drugs ...
September 20, 2017
Altimmune Announces its Phase 2 Flu Vaccine Trial with NasoVAX Open for Enrollment
GAITHERSBURG, Md., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced that they have been cleared by the FDA ...
September 20, 2017
AIT Therapeutics to Present at the Ladenburg Thalmann 2017 Healthcare Conference
REHOVOT, Israel and NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases with ...
September 18, 2017
Ignyta to Present at the Ladenburg Thalmann 2017 Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)-- Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jonathan Lim, M.D., its Chairman and Chief Executive Officer, ...
September 18, 2017
BioTime Awarded Grant from the NIH
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American:BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that it has been ...
September 18, 2017
Kamada Announces CFO Transition
REHOVOT, Israel, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, today announced that Gil ...
September 18, 2017
HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements
TUCSON, Ariz., Sept. 18, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today ...
September 18, 2017
Eiger Announces Appointment of Biopharmaceutical Industry Veteran Evan Loh, MD to its Board of Directors
PALO ALTO, Calif., Sept. 18, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of therapies for rare diseases, announced today the ...
September 18, 2017
Prothena Presents New Research Supporting Clinical Relevance of Cardiac Biomarker NT-proBNP in AL Amyloidosis
DUBLIN, Ireland, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
Page 101 of 127